TMCI Q2 2023 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena

TMCITreace Medical Concepts, Inc.

$104M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$42M+40.0% YoY

Gross Profit

$34M81.7% margin

Operating Income

-$13M-31.1% margin

Net Income

-$12M-29.2% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-0.6%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$13M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$250M

Total Liabilities

$100M

Stockholders' Equity

$150M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$30M	+40.0%
Gross Profit	$34M	$25M	+38.9%
Operating Income	-$13M	-$12M	-9.4%
Net Income	-$12M	-$17M	+28.8%